Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001193125-23-252369
Filing Date
2023-10-06
Accepted
2023-10-06 16:06:37
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-4/A d540258ds4a.htm S-4/A 3756784
2 EX-23.1 d540258dex231.htm EX-23.1 1357
3 EX-23.2 d540258dex232.htm EX-23.2 1770
4 EX-23.3 d540258dex233.htm EX-23.3 1818
5 EX-99.2 d540258dex992.htm EX-99.2 2065
6 GRAPHIC g540258g02z05.jpg GRAPHIC 61236
7 GRAPHIC g540258g03g42.jpg GRAPHIC 50040
8 GRAPHIC g540258g03m39.jpg GRAPHIC 24379
9 GRAPHIC g540258g54e66.jpg GRAPHIC 196838
10 GRAPHIC g540258g58q60.jpg GRAPHIC 79732
11 GRAPHIC g540258g89o75.jpg GRAPHIC 98619
  Complete submission text file 0001193125-23-252369.txt   4464965
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-274758 | Film No.: 231314284
SIC: 2834 Pharmaceutical Preparations